Coral Laboratories [CORALAB] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Coral Laboratories

BSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Coral Laboratories wins in 13 metrics, Innova Captab wins in 5 metrics, with 0 ties. Coral Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCoral LaboratoriesInnova CaptabBetter
P/E Ratio (TTM)10.4137.44Coral Laboratories
Price-to-Book Ratio0.935.07Coral Laboratories
Debt-to-Equity Ratio1.7735.24Coral Laboratories
PEG Ratio-0.157.14Coral Laboratories
EV/EBITDA4.6426.94Coral Laboratories
Profit Margin (TTM)17.54%9.98%Coral Laboratories
Operating Margin (TTM)9.19%11.68%Innova Captab
EBITDA Margin (TTM)9.19%11.68%Innova Captab
Return on Equity12.01%13.37%Innova Captab
Return on Assets (TTM)10.53%8.12%Coral Laboratories
Free Cash Flow (TTM)$-41.67M$-1.09BCoral Laboratories
Dividend Yield0.29%N/AN/A
1-Year Return-41.03%16.46%Innova Captab
Price-to-Sales Ratio (TTM)1.833.74Coral Laboratories
Enterprise Value$823.11M$51.37BInnova Captab
EV/Revenue Ratio0.813.95Coral Laboratories
Gross Profit Margin (TTM)53.58%37.21%Coral Laboratories
Revenue per Share (TTM)$286$227Coral Laboratories
Earnings per Share (Diluted)$50.14$22.70Coral Laboratories
Beta (Stock Volatility)0.70N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Coral Laboratories vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Coral Laboratories
Innova Captab
Coral Laboratories Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Coral Laboratories-0.90%3.35%2.66%-12.43%-19.72%-36.61%
Innova Captab-2.09%0.46%-4.62%-2.11%-0.23%-24.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Coral Laboratories-41.03%95.66%39.82%8.95%318.43%440.61%
Innova Captab16.46%53.72%53.72%53.72%53.72%53.72%

News Based Sentiment: Coral Laboratories vs Innova Captab

Coral Laboratories

News based Sentiment: MIXED

Coral Laboratories experienced a share price increase in October, but longer-term trends remain negative. The board's actions regarding cost audits and leadership appointments suggest a focus on stability and compliance, creating a mixed investment narrative.

View Coral Laboratories News Sentiment Analysis

Innova Captab

News based Sentiment: POSITIVE

Innova Captab reported impressive revenue and profit growth for both Q1 FY2026 and the full fiscal year 2025-26, supported by a 'Buy' rating from JM Financial. While there were shifts in shareholding, particularly a decrease in FII holdings, the overall narrative points towards a positive trajectory for the company.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Coral Laboratories vs Innova Captab

MetricCORALABINNOVACAP
Market Information
Market Cap i₹1.98B₹48.64B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i62233,824
90 Day Avg. Volume i88740,665
Last Close₹516.55₹832.25
52 Week Range₹442.55 - ₹859.00₹662.00 - ₹1,260.00
% from 52W High-39.87%-33.95%
All-Time High₹1,190.00 (Jul 24, 2017)₹1,260.00 (Jan 06, 2025)
% from All-Time High-56.59%-33.95%
Growth Metrics
Quarterly Revenue Growth-0.41%0.20%
Quarterly Earnings Growth-0.71%0.05%
Financial Health
Profit Margin (TTM) i0.18%0.10%
Operating Margin (TTM) i0.09%0.12%
Return on Equity (TTM) i0.12%0.13%
Debt to Equity (MRQ) i1.7735.24
Cash & Liquidity
Book Value per Share (MRQ)₹562.96₹167.66
Cash per Share (MRQ)₹300.75₹11.41
Operating Cash Flow (TTM) i₹106.44M₹282.88M
Levered Free Cash Flow (TTM) i₹241.56M₹1.28B
Dividends
Last 12-Month Dividend Yield i0.29%N/A
Last 12-Month Dividend i₹1.50N/A

Valuation & Enterprise Metrics Analysis: Coral Laboratories vs Innova Captab

MetricCORALABINNOVACAP
Price Ratios
P/E Ratio (TTM) i10.4137.44
Forward P/E i8.9820.01
PEG Ratio i-0.157.14
Price to Sales (TTM) i1.833.74
Price to Book (MRQ) i0.935.07
Market Capitalization
Market Capitalization i₹1.98B₹48.64B
Enterprise Value i₹823.11M₹51.37B
Enterprise Value Metrics
Enterprise to Revenue i0.813.95
Enterprise to EBITDA i4.6426.94
Risk & Other Metrics
Beta i0.70N/A
Book Value per Share (MRQ) i₹562.96₹167.66

Financial Statements Comparison: Coral Laboratories vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CORALABINNOVACAP
Revenue/Sales i₹188.21M₹3.52B
Cost of Goods Sold i₹87.37M₹2.21B
Gross Profit i₹100.84M₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹17.29M₹410.54M
EBITDA i₹42.30M₹565.82M
Pre-Tax Income i₹37.19M₹426.77M
Income Tax i₹11.55M₹116.62M
Net Income (Profit) i₹25.64M₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CORALABINNOVACAP
Cash & Equivalents i₹34.06M₹155.19M
Total Current Assets i₹1.77B₹7.03B
Total Current Liabilities i₹249.58M₹3.53B
Long-Term Debt i₹0₹2.45B
Total Shareholders Equity i₹2.01B₹9.59B
Retained Earnings i₹1.71B₹4.53B
Property, Plant & Equipment i₹217.44M₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CORALABINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCORALABINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i62233,824
Average Daily Volume (90 Day) i88740,665
Shares Outstanding i3.57M57.22M
Float Shares i803,04015.70M
% Held by Insiders i0.79%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Coral Laboratories vs Innova Captab

MetricCORALABINNOVACAP
Last 12-Month Dividend i₹1.50N/A
Last 12-Month Dividend Yield i0.29%N/A
3-Year Avg Annual Dividend i₹1.17N/A
3-Year Avg Dividend Yield i0.26%N/A
3-Year Total Dividends i₹3.50N/A
Ex-Dividend DateSep 19, 2025N/A